Prevention of bedrest induced orthostatism by 9-alpha-fluorohydrocortisone.
D001513:Beds; D001811:Blood Volume Determination; D002986:Clinical Trials as Topic; D005461:Fluorine / Q000627:therapeutic use; D006112:Gravitation; D006339:Heart Rate; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology / Q000627:therapeutic use*; D007024:Hypotension, Orthostatic / Q000503:physiopathology / Q000517:prevention & control*; D008297:Male; D005082:Physical Exertion; D010919:Placebos; D010953:Plasma Volume / Q000187:drug effects; D012146:Rest; D014882:Water-Electrolyte Balance
D010919:Placebos; D005461:Fluorine; D006854:Hydrocortisone